The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies

Pharmacology and Therapeutics

Volumn 129, Issue 2, 2011, Pages 172-184

  Grek, Christina L ^a   Townsend, Danyelle M ^a   Tew, Kenneth D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cancer; Glutathione (GHS); Immune response; Myeloproliferation; Redox signaling; Thiol

Indexed keywords

ACETYLCYSTEINE; AMIFOSTINE; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; BNP 77987; DIMESNA; DISULFIDE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; THIOL; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; CANCER CELL; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; MICROENVIRONMENT; NEOPLASM; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REDOX STRESS; REGULATORY MECHANISM; SELF CONCEPT; SPECIES; STEM CELL MOBILIZATION;

EID: 79151472172     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2010.09.008     Document Type: Review

References (201)

1. G.B. Adams, K.T. Chabner, I.R. Alley, D.P. Olson, Z.M. Szczepiorkowski, and M.C. Poznansky Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor Nature 439 7076 2006 599 603
2. T. Ahmad, and H. Frischer Active site-specific inhibition by 1, 3-bis(2-chloroethyl)-1-nitrosourea of two genetically homologous flavoenzymes: glutathione reductase and lipoamide dehydrogenase J Lab Clin Med 105 4 1985 464 471
3. B. Akerlund, C. Jarstrand, B. Lindeke, A. Sonnerborg, A.C. Akerblad, and O. Rasool Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial Eur J Clin Pharmacol 50 6 1996 457 461
4. J. Alexandre, C. Nicco, C. Chereau, A. Laurent, B. Weill, and F. Goldwasser Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir J Natl Cancer Inst 98 4 2006 236 244
5. G. Angelini, S. Gardella, M. Ardy, M.R. Ciriolo, G. Filomeni, and G. Di Trapani Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation Proc Natl Acad Sci USA 99 3 2002 1491 1496
6. F. Arai, H. Yoshihara, K. Hosokawa, Y. Nakamura, Y. Gomei, and H. Iwasaki Niche regulation of hematopoietic stem cells in the endosteum Ann NY Acad Sci 1176 2009 36 46
7. H.H. Bailey, R.T. Mulcahy, K.D. Tutsch, R.Z. Arzoomanian, D. Alberti, and M.B. Tombes Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: An attempt at modulation of glutathione J Clin Oncol 12 1 1994 194 205
8. H.H. Bailey, G. Ripple, K.D. Tutsch, R.Z. Arzoomanian, D. Alberti, and C. Feierabend Phase I study of continuous-infusion L-S, R-buthionine sulfoximine with intravenous melphalan J Natl Cancer Inst 89 23 1997 1789 1796
9. A.F. Baker, T. Dragovich, W.R. Tate, R.K. Ramanathan, D. Roe, and C.H. Hsu The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma J Lab Clin Med 147 2 2006 83 90
10. M. Baldini, and C. Sacchetti Effect of cystine and cysteine on human bone marrow cultured in medium deficient in amino acids Rev Hématol 8 1 1953 3 19
11. E.G. Barrett, C. Johnston, G. Oberdorster, and J.N. Finkelstein Antioxidant treatment attenuates cytokine and chemokine levels in murine macrophages following silica exposure Toxicol Appl Pharmacol 158 3 1999 211 220
12. C. Berndt, C.H. Lillig, and A. Holmgren Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: Implications for diseases in the cardiovascular system Am J Physiol Heart Circ Physiol 292 3 2007 H1227 H1236
13. R. Bertini, O.M. Howard, H.F. Dong, J.J. Oppenheim, C. Bizzarri, and R. Sergi Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells J Exp Med 189 11 1999 1783 1789
14. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 7 1997 730 737
15. R.R. Bowers, D. Townsend, Y. Manevich, T. Garret, C.J. Pazoles, and K.D. Tew The redox modulator NOV-002 inhibits proliferation of ovarian tumor cells but increases proliferation of myeloid cells [abstract 1615] American Association for Cancer Research Annual Meeting: April 17-21, Washington DC 2010
16. R. Brigelius-Flohe Glutathione peroxidases and redox-regulated transcription factors Biol Chem 387 10-11 2006 1329 1335
17. L.M. Calvi, G.B. Adams, K.W. Weibrecht, J.M. Weber, D.P. Olson, and M.C. Knight Osteoblastic cells regulate the haematopoietic stem cell niche Nature 425 6960 2003 841 846
18. R.L. Capizzi The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine Semin Oncol 26 2 Suppl 7 1999 3 21
19. P. Castellani, G. Angelini, L. Delfino, A. Matucci, and A. Rubartelli The thiol redox state of lymphoid organs is modified by immunization: Role of different immune cell populations Eur J Immunol 38 9 2008 2419 2425
20. O. Cetinkale, O. Senel, and R. Bulan The effect of antioxidant therapy on cell-mediated immunity following burn injury in an animal model Burns 25 2 1999 113 118
21. M.K. Cha, K.H. Suh, and I.H. Kim Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma J Exp Clin Cancer Res 28 2009 93
22. S.M. Chambers, C.A. Shaw, C. Gatza, C.J. Fisk, L.A. Donehower, and M.A. Goodell Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation PLoS Biol 5 8 2007 e201
23. S.H. Cheshier, S.J. Morrison, X. Liao, and I.L. Weissman In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells Proc Natl Acad Sci USA 96 6 1999 3120 3125
24. M.G. Cipolleschi, P. Dello Sbarba, and M. Olivotto The role of hypoxia in the maintenance of hematopoietic stem cells Blood 82 7 1993 2031 2037
25. D.S. Collins, E.R. Unanue, and C.V. Harding Reduction of disulfide bonds within lysosomes is a key step in antigen processing J Immunol 147 12 1991 4054 4059
26. C.R. Culy, and C.M. Spencer Amifostine: An update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome Drugs 61 5 2001 641 684
27. D. Daniel, and J. Crawford Myelotoxicity from chemotherapy Semin Oncol 33 1 2006 74 85
28. B. Das, R. Antoon, R. Tsuchida, S. Lotfi, O. Morozova, and W. Farhat Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth Neoplasia 10 10 2008 1105 1119
29. W. Davis Jr., Z. Ronai, and K.D. Tew Cellular thiols and reactive oxygen species in drug-induced apoptosis J Pharmacol Exp Ther 296 1 2001 1 6
30. S. Dedieu, X. Canron, H.R. Rezvani, M. Bouchecareilh, F. Mazurier, and R. Sinisi The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A BMC Med 8 2010 19
31. L.E. DeForge, J.C. Fantone, J.S. Kenney, and D.G. Remick Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood J Clin Invest 90 5 1992 2123 2129
32. C.M. Diaz-Montero, A. Perez, S. Zidane, C.J. Pazoles, and A.J. Montero Immunomodulatory activity of NOV-002 potentiates the anti-tumor efficacy of cyclophosphamide in the CT26 murine colon cancer model [abstract 5620] American Association for Cancer Research Annual Meeting: April 17-21, Washington DC 2010
33. 2 production and S-thiolation Free Radic Biol Med 27 5-6 1999 623 635
34. P. Drane, A. Bravard, V. Bouvard, and E. May Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis Oncogene 20 4 2001 430 439
35. W. Droge, K. Schulze-Osthoff, S. Mihm, D. Galter, H. Schenk, and H.P. Eck Functions of glutathione and glutathione disulfide in immunology and immunopathology FASEB J 8 14 1994 1131 1138
36. S.M. El-Sayed el, A.A. Abdel-Aziz, G.K. Helal, S. Saleh, and A.S. Saad Protective effect of N-acetylcysteine against carmustine-induced myelotoxicity in rats Food Chem Toxicol 48 6 2010 1576 1580
37. L. Erker, R. Schubert, H. Yakushiji, C. Barlow, D. Larson, and J.B. Mitchell Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor Hum Mol Genet 14 12 2005 1699 1708
38. R.G. Evans, C. Wheatley, C. Engel, J. Nielsen, and L.J. Ciborowski Modification of the bone marrow toxicity of cis-diamminedichloroplatinum(II) in mice by diethyldithiocarbamate Cancer Res 44 9 1984 3686 3690
39. E. Eylar, C. Rivera-Quinones, C. Molina, I. Baez, F. Molina, and C.M. Mercado N-acetylcysteine enhances T cell functions and T cell growth in culture Int Immunol 5 1 1993 97 101
40. J.W. Fahey, X. Haristoy, P.M. Dolan, T.W. Kensler, I. Scholtus, and K.K. Stephenson Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors Proc Natl Acad Sci USA 99 11 2002 7610 7615
41. M.A. Fakhfakh, A. Fournet, E. Prina, J.F. Mouscadet, X. Franck, and R. Hocquemiller Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections Bioorg Med Chem 11 23 2003 5013 5023
42. M. Fratelli, H. Demol, M. Puype, S. Casagrande, I. Eberini, and M. Salmona Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes Proc Natl Acad Sci USA 99 6 2002 3505 3510
43. A. Fraternale, M.F. Paoletti, A. Casabianca, L. Nencioni, E. Garaci, and A.T. Palamara GSH and analogs in antiviral therapy Mol Aspects Med 30 1-2 2009 99 110
44. H.S. Friedman, O.M. Colvin, O.W. Griffith, B. Lippitz, G.B. Elion, and S.C. Schold Jr. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion J Natl Cancer Inst 81 7 1989 524 527
45. A. Garcia-Lora, M. Martinez, S. Pedrinaci, and F. Garrido Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line Cancer Immunol Immunother 52 1 2003 59 64
46. A. Garcia-Lora, S. Pedrinaci, and F. Garrido Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line Cancer Immunol Immunother 50 4 2001 191 198
47. L. Gate, R.S. Majumdar, A. Lunk, and K.D. Tew Increased myeloproliferation in glutathione S-transferase pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways J Biol Chem 279 10 2004 8608 8616
48. Y. Gazitt Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules J Hematother Stem Cell Res 10 2 2001 229 236
49. K.A. Gelderman, M. Hultqvist, J. Holmberg, P. Olofsson, and R. Holmdahl T cell surface redox levels determine T cell reactivity and arthritis susceptibility Proc Natl Acad Sci USA 103 34 2006 12831 12836
50. J. Gil, A. Stembalska, K.A. Pesz, and M.M. Sasiadek Cancer stem cells: the theory and perspectives in cancer therapy J Appl Genet 49 2 2008 193 199
51. G.I. Giles The redox regulation of thiol dependent signaling pathways in cancer Curr Pharm Des 12 34 2006 4427 4443
52. L. Giordani, M.G. Quaranta, W. Malorni, M. Boccanera, E. Giacomini, and M. Viora N-acetylcysteine inhibits the induction of an antigen-specific antibody response down-regulating CD40 and CD27 co-stimulatory molecules Clin Exp Immunol 129 2 2002 254 264
53. D. Gius, and D.R. Spitz Redox signaling in cancer biology Antioxid Redox Signal 8 7-8 2006 1249 1252
54. P. Gosset, B. Wallaert, A.B. Tonnel, and C. Fourneau Thiol regulation of the production of TNF-alpha, IL-6 and IL-8 by human alveolar macrophages Eur Respir J 14 1 1999 98 105
55. D.J. Grdina, J.S. Murley, and Y. Kataoka Radioprotectants: Current status and new directions Oncology 63 Suppl 2 2002 2 10
56. C.L. Grek, D.M. Townsend, J.D. Uys, J. Christopher, J. Pazoles, and K.D. Tew Serpin-A1 and A3 as potential pharmacodynamic biomarkers for NOV-002, a redox modulating anticancer agent. [abstract 430] American Association for Cancer Research Annual Meeting: April 17-21, Washington DC 2010
57. J.J. Haddad Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation Biochem Biophys Res Commun 296 4 2002 847 856
58. J.J. Haddad, R.E. Olver, and S.C. Land Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells J Biol Chem 275 28 2000 21130 21139
59. J.J. Haddad, B. Safieh-Garabedian, N.E. Saade, and S.C. Land Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium J Pharmacol Exp Ther 296 3 2001 996 1005
60. T. Hadzic, L. Li, N. Cheng, S.A. Walsh, D.R. Spitz, and C.M. Knudson The role of low molecular weight thiols in T lymphocyte proliferation and IL-2 secretion J Immunol 175 12 2005 7965 7972
61. D.L. Hamilos, P. Zelarney, and J.J. Mascali Lymphocyte proliferation in glutathione-depleted lymphocytes: Direct relationship between glutathione availability and the proliferative response Immunopharmacology 18 3 1989 223 235
62. R. Harper, K. Wu, M.M. Chang, K. Yoneda, R. Pan, and S.P. Reddy Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione Am J Respir Cell Mol Biol 25 2 2001 178 185
63. F.H. Hausheer, P. Kanter, S. Cao, K. Haridas, P. Seetharamulu, and D. Reddy Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents Semin Oncol 25 5 1998 584 599
64. D.W. Hedley, T.J. McElwain, J.L. Millar, and M.Y. Gordon Acceleration of bone-marrow recovery by pre-treatment with cyclophosphamide in patients receiving high-dose melphalan Lancet 2 8097 1978 966 968
65. G.K. Helal, and O.K. Helal Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats Arch Toxicol 83 1 2009 87 94
66. Y. Hu, D.G. Rosen, Y. Zhou, L. Feng, G. Yang, and J. Liu Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: Role in cell proliferation and response to oxidative stress J Biol Chem 280 47 2005 39485 39492
67. B.J. Huntly, and D.G. Gilliland Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemia Cancer Cell 6 3 2004 199 201
68. C.Y. Hwang, Y.S. Ryu, M.S. Chung, K.D. Kim, S.S. Park, and S.K. Chae Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1 Oncogene 23 55 2004 8868 8875
69. T. Ishii, Y. Sugita, and S. Bannai Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine J Cell Physiol 133 2 1987 330 336
70. K. Ito, A. Hirao, F. Arai, K. Takubo, S. Matsuoka, and K. Miyamoto Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells Nat Med 12 4 2006 446 451
71. H. Iwasaki, and T. Suda Cancer stem cells and their niche Cancer Sci 100 7 2009 1166 1172
72. J. Jain, C. Loh, and A. Rao Transcriptional regulation of the IL-2 gene Curr Opin Immunol 7 3 1995 333 342
73. Y.Y. Jang, and S.J. Sharkis A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche Blood 110 8 2007 3056 3063
74. R.J. Jariwalla, J. Lalezari, D. Cenko, S.E. Mansour, A. Kumar, and B. Gangapurkar Restoration of blood total glutathione status and lymphocyte function following alpha-lipoic acid supplementation in patients with HIV infection J Altern Complement Med 14 2 2008 139 146
75. P. Jeannin, Y. Delneste, S. Lecoanet-Henchoz, J.F. Gauchat, P. Life, and D. Holmes Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis J Exp Med 182 6 1995 1785 1792
76. S. Jenderny, H. Lin, T. Garrett, K.D. Tew, and D.M. Townsend Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicity Biomed Pharmacother 64 1 2010 73 76
77. M. Jeong, Z.H. Piao, M.S. Kim, S.H. Lee, S. Yun, and H.N. Sun Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions J Immunol 183 4 2009 2495 2505
78. E. Jimenez-Medina, E. Berruguilla, I. Romero, I. Algarra, A. Collado, and F. Garrido The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis BMC Cancer 8 2008 78
79. D.P. Jones Radical-free biology of oxidative stress Am J Physiol Cell Physiol 295 4 2008 C849 C868
80. P.A. Jordan, and J.M. Gibbins Extracellular disulfide exchange and the regulation of cellular function Antioxid Redox Signal 8 3-4 2006 312 324
81. W.G. Kaelin Jr. The concept of synthetic lethality in the context of anticancer therapy Nat Rev Cancer 5 9 2005 689 698
82. Y. Kariya, N. Inoue, T. Kihara, N. Okamoto, K. Sugie, and T. Mori Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2 Immunol Lett 31 3 1992 241 245
83. T. Katahira, T. Takayama, K. Miyanishi, T. Hayashi, T. Ikeda, and Y. Takahashi Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV) Clin Cancer Res 10 23 2004 7934 7940
84. E. Kellen, M. Hemelt, K. Broberg, K. Golka, V.N. Kristensen, and R.J. Hung Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review Am J Epidemiol 165 11 2007 1221 1230
85. G.S. Kelly Clinical applications of N-acetylcysteine Altern Med Rev 3 2 1998 114 127
86. A. Kohler, V. Schmithorst, M.D. Filippi, M.A. Ryan, D. Daria, and M. Gunzer Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones Blood 114 2 2009 290 298
87. Y. Koike, T. Hisada, M. Utsugi, T. Ishizuka, Y. Shimizu, and A. Ono Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice Am J Respir Cell Mol Biol 37 3 2007 322 329
88. A.A. Konstantinov, A.V. Peskin, E. Popova, G.B. Khomutov, and E.K. Ruuge Superoxide generation by the respiratory chain of tumor mitochondria Biochim Biophys Acta 894 1 1987 1 10
89. A.E. Korst, C.M. Eeltink, J.B. Vermorken, and W.J. van der Vijgh Pharmacokinetics of amifostine and its metabolites in patients Eur J Cancer 33 9 1997 1425 1429
90. M.I. Koukourakis, A. Giatromanolaki, W. Chong, C. Simopoulos, A. Polychronidis, and E. Sivridis Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha Cancer Chemother Pharmacol 53 1 2004 8 14
91. S.M. Kraggerud, J. Oldenburg, G.I. Alnaes, M. Berg, V.N. Kristensen, and S.D. Fossa Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: Associations with primary and post-chemotherapy tumor histology Pharmacogenet Genomics 19 10 2009 751 759
92. C. Ladner, G. Ehninger, K.F. Gey, and M.R. Clemens Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen Cancer Chemother Pharmacol 25 3 1989 210 212
93. L. Laterveer, I.J. Lindley, D.P. Heemskerk, J.A. Camps, E.K. Pauwels, and R. Willemze Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8 Blood 87 2 1996 781 788
94. A. Laurent, C. Nicco, C. Chereau, C. Goulvestre, J. Alexandre, and A. Alves Controlling tumor growth by modulating endogenous production of reactive oxygen species Cancer Res 65 3 2005 948 956
95. E.M. Levy, J. Wu, M. Salibian, and P.H. Black The effect of changes in thiol subcompartments on T-cell colony formation and cell cycle progression: relevance to AIDS Cell Immunol 140 2 1992 370 380
96. A.F. List, F. Brasfield, R. Heaton, B. Glinsmann-Gibson, L. Crook, and R. Taetle Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome Blood 90 9 1997 3364 3369
97. A.F. List, R. Heaton, B. Glinsmann-Gibson, and R.L. Capizzi Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity Semin Oncol 23 4 Suppl 8 1996 58 63
98. F. Liu, V.E. Ooi, and S.T. Chang Free radical scavenging activities of mushroom polysaccharide extracts Life Sci 60 10 1997 763 771
99. C. Lo Celso, J.W. Wu, and C.P. Lin In vivo imaging of hematopoietic stem cells and their microenvironment J Biophotonics 2 11 2009 619 631
100. Y. Makino, N. Yoshikawa, K. Okamoto, K. Hirota, J. Yodoi, and I. Makino Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function J Biol Chem 274 5 1999 3182 3188
101. W. Malorni, R. Rivabene, M.T. Santini, and G. Donelli N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells FEBS Lett 327 1 1993 75 78
102. L. Marcu, and I. Olver Tirapazamine: From bench to clinical trials Curr Clin Pharmacol 1 1 2006 71 79
103. L.J. Matthias, P.T. Yam, X.M. Jiang, N. Vandegraaff, P. Li, and P. Poumbourios Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1 Nat Immunol 3 8 2002 727 732
104. A.M. Maurer, Y. Liu, J.P. Caen, and Z.C. Han Ex vivo expansion of megakaryocytic cells Int J Hematol 71 3 2000 203 210
105. K. Mekouar, J.F. Mouscadet, D. Desmaele, F. Subra, H. Leh, and D. Savoure Styrylquinoline derivatives: A new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells J Med Chem 41 15 1998 2846 2857
106. J.L. Millar, and B.N. Hudspith Sparing effect of cyclophosphamide (NSC-26271) pretreatment on animals lethally treated with gamma-irradiation Cancer Treat Rep 60 4 1976 409 414
107. J.L. Millar, B.N. Hudspith, and N.M. Blackett Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan Br J Cancer 32 2 1975 193 198
108. J.B. Mitchell, S. Xavier, A.M. DeLuca, A.L. Sowers, J.A. Cook, and M.C. Krishna A low molecular weight antioxidant decreases weight and lowers tumor incidence Free Radic Biol Med 34 1 2003 93 102
109. K. Miyamoto, K.Y. Araki, K. Naka, F. Arai, K. Takubo, and S. Yamazaki Foxo3a is essential for maintenance of the hematopoietic stem cell pool Cell Stem Cell 1 1 2007 101 112
110. K. Miyazaki, N. Noda, S. Okada, Y. Hagiwara, M. Miyata, and I. Sakurabayashi Elevated serum level of thioredoxin in patients with hepatocellular carcinoma Biotherapy 11 4 1998 277 288
111. M.M. Monick, L. Samavati, N.S. Butler, M. Mohning, L.S. Powers, and T. Yarovinsky Intracellular thiols contribute to Th2 function via a positive role in IL-4 production J Immunol 171 10 2003 5107 5115
112. A.S. Morgan, P.J. Ciaccio, K.D. Tew, and L.M. Kauvar Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines Cancer Chemother Pharmacol 37 4 1996 363 370
113. Y. Murata, T. Shimamura, and J. Hamuro The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production Int Immunol 14 2 2002 201 212
114. R.R. Nair, J. Tolentino, and L.A. Hazlehurst The bone marrow microenvironment as a sanctuary for minimal residual disease in CML Biochem Pharmacol 2010
115. K. Naka, T. Muraguchi, T. Hoshii, and A. Hirao Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells Antioxid Redox Signal 10 11 2008 1883 1894
116. K. Naka, M. Ohmura, and A. Hirao Regulation of the self-renewal ability of tissue stem cells by tumor-related genes Cancer Biomark 3 4-5 2007 193 201
117. H. Nakamura, J. Bai, Y. Nishinaka, S. Ueda, T. Sasada, and G. Ohshio Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer Cancer Detect Prev 24 1 2000 53 60
118. H. Nakamura, L.A. Herzenberg, J. Bai, S. Araya, N. Kondo, and Y. Nishinaka Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis Proc Natl Acad Sci USA 98 26 2001 15143 15148
119. H. Nakamura, H. Masutani, and J. Yodoi Redox imbalance and its control in HIV infection Antioxid Redox Signal 4 3 2002 455 464
120. E.A. Neuwelt, M.A. Pagel, B.P. Hasler, T.G. Deloughery, and L.L. Muldoon Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model Cancer Res 61 21 2001 7868 7874
121. E.A. Neuwelt, M.A. Pagel, D.F. Kraemer, D.R. Peterson, and L.L. Muldoon Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model J Pharmacol Exp Ther 309 2 2004 594 599
122. S.K. Nilsson, H.M. Johnston, and J.A. Coverdale Spatial localization of transplanted hemopoietic stem cells: Inferences for the localization of stem cell niches Blood 97 8 2001 2293 2299
123. I. Novak, and B. Kovac UV photoelectron spectroscopic study of substituent effects in quinoline derivatives J Org Chem 69 15 2004 5005 5010
124. M.L. O'Brien, B. Vulevic, S. Freer, J. Boyd, H. Shen, and K.D. Tew Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein J Pharmacol Exp Ther 291 3 1999 1348 1355
125. P.J. O'Dwyer, T.C. Hamilton, F.P. LaCreta, J.M. Gallo, D. Kilpatrick, and T. Halbherr Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer J Clin Oncol 14 1 1996 249 256
126. J.J. O'Shea, M. Gadina, and R.D. Schreiber Cytokine signaling in 2002: New surprises in the Jak/Stat pathway Cell 109 Suppl 2002 S121 S131
127. T.D. Oberley, and L.W. Oberley Antioxidant enzyme levels in cancer Histol Histopathol 12 2 1997 525 535
128. V.E. Ooi, and F. Liu Immunomodulation and anti-cancer activity of polysaccharide-protein complexes Curr Med Chem 7 7 2000 715 729
129. Z. Pawlowicz, B.A. Zachara, U. Trafikowska, A. Maciag, E. Marchaluk, and A. Nowicki Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer J Trace Elem Electrolytes Health Dis 5 4 1991 275 277
130. Pazoles C. J., Gernstein, H. (2006). NOV-002, a chemoprotectant/ immunomodulator, added to first line carboplatin/paclitaxel in advanced non-small cell lung cancer (NSCLC): a randomized phase 1/2, open label, controlled study [abstract 17021]. Journal of Clinical Oncology, ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement),17021.
131. S. Pedrinaci, I. Algarra, and F. Garrido Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line Int J Clin Lab Res 29 4 1999 135 140
132. P. Pei, M.P. Horan, R. Hille, C.F. Hemann, S.P. Schwendeman, and S.R. Mallery Reduced nonprotein thiols inhibit activation and function of MMP-9: Implications for chemoprevention Free Radic Biol Med 41 8 2006 1315 1324
133. K. Pekkari, J. Avila-Carino, A. Bengtsson, R. Gurunath, A. Scheynius, and A. Holmgren Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes Blood 97 10 2001 3184 3190
134. L. Pendyala, G. Schwartz, P. Smith, J. Zdanowicz, M. Murphy, and F. Hausheer Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy Cancer Chemother Pharmacol 51 5 2003 376 384
135. J.D. Peterson, L.A. Herzenberg, K. Vasquez, and C. Waltenbaugh Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns Proc Natl Acad Sci USA 95 6 1998 3071 3076
136. O. Pluquet, S. North, A. Bhoumik, K. Dimas, Z. Ronai, and P. Hainaut The cytoprotective aminothiol WR1065 activates p53 through a non-genotoxic signaling pathway involving c-Jun N-terminal kinase J Biol Chem 278 14 2003 11879 11887
137. G. Powis, and D.L. Kirkpatrick Thioredoxin signaling as a target for cancer therapy Curr Opin Pharmacol 7 4 2007 392 397
138. Przygodzka, P., Ramstedt, B., Tengel, T., Larsson, G., & Wilczynska, M. Bomapin is a redox-sensitive nuclear serpin that affects responsiveness of myeloid progenitor cells to growth environment. BMC Cell Biol 11, 30.
139. S. Raimondi, V. Paracchini, H. Autrup, J.M. Barros-Dios, S. Benhamou, and P. Boffetta Meta- and pooled analysis of GSTT1 and lung cancer: A HuGE-GSEC review Am J Epidemiol 164 11 2006 1027 1042
140. B. Ramanathan, K.Y. Jan, C.H. Chen, T.C. Hour, H.J. Yu, and Y.S. Pu Resistance to paclitaxel is proportional to cellular total antioxidant capacity Cancer Res 65 18 2005 8455 8460
141. M. Ramos-Gomez, M.K. Kwak, P.M. Dolan, K. Itoh, M. Yamamoto, and P. Talalay Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice Proc Natl Acad Sci USA 98 6 2001 3410 3415
142. R. Reliene, and R.H. Schiestl Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice DNA Repair (Amst) 5 7 2006 852 859
143. I. Ribizzi, J.W. Darnowski, F.A. Goulette, M.R. Sertoli, and P. Calabresi Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line Leuk Res 24 6 2000 519 525
144. E. Righi, V. Lindstrom, C. Linton, P. Leblanc, M. Santosuosso, and C. Pazoles Positive immunomodulatory effects of NOV-002, an oxidized glutathione mimetic, in a murine model of ovarian cancer AACR Conference on Tumor Immunology, December 2, Miami, FL 2008
145. R.L. Roberts, V.R. Aroda, and B.J. Ank N-acetylcysteine enhances antibody-dependent cellular cytotoxicity in neutrophils and mononuclear cells from healthy adults and human immunodeficiency virus-infected patients J Infect Dis 172 6 1995 1492 1502
146. M.F. Romano, A. Lamberti, R. Bisogni, C. Garbi, A.M. Pagnano, and P. Auletta Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kappaB/Rel transcription factors Blood 94 12 1999 4060 4066
147. L. Romero, K. Andrews, L. Ng, K. O'Rourke, A. Maslen, and G. Kirby Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells Biochem J 400 1 2006 135 141
148. D.J. Rossi, D. Bryder, J. Seita, A. Nussenzweig, J. Hoeijmakers, and I.L. Weissman Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age Nature 447 7145 2007 725 729
149. B.H. Rovin, J.A. Dickerson, L.C. Tan, and J. Fassler Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status Cytokine 9 3 1997 178 186
150. J.E. Ruscoe, L.A. Rosario, T. Wang, L. Gate, P. Arifoglu, and C.R. Wolf Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways J Pharmacol Exp Ther 298 1 2001 339 345
151. A.A. Sablina, A.V. Budanov, G.V. Ilyinskaya, L.S. Agapova, J.E. Kravchenko, and P.M. Chumakov The antioxidant function of the p53 tumor suppressor Nat Med 11 12 2005 1306 1313
152. M. Sagara, J. Satoh, R. Wada, S. Yagihashi, K. Takahashi, and M. Fukuzawa Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine Diabetologia 39 3 1996 263 269
153. P. Sangeetha, U.N. Das, R. Koratkar, and P. Suryaprabha Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer Free Radic Biol Med 8 1 1990 15 19
154. Y. Sawada, H. Kayakiri, Y. Abe, T. Mizutani, N. Inamura, and M. Asano Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks J Med Chem 47 11 2004 2853 2863
155. N. Saydam, A. Kirb, O. Demir, E. Hazan, O. Oto, and O. Saydam Determination of glutathione, glutathione reductase, glutathione peroxidase and glutathione S-transferase levels in human lung cancer tissues Cancer Lett 119 1 1997 13 19
156. R. Schubert, L. Erker, C. Barlow, H. Yakushiji, D. Larson, and A. Russo Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice Hum Mol Genet 13 16 2004 1793 1802
157. U. Schwertassek, Y. Balmer, M. Gutscher, L. Weingarten, M. Preuss, and J. Engelhard Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1 EMBO J 26 13 2007 3086 3097
158. S. Seemann, and P. Hainaut Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity Oncogene 24 24 2005 3853 3863
159. E. Shacter, J.A. Williams, R.M. Hinson, S. Senturker, and Y.J. Lee Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis Blood 96 1 2000 307 313
160. E. Shaulian, and M. Karin AP-1 in cell proliferation and survival Oncogene 20 19 2001 2390 2400
161. M.D. Shelton, P.B. Chock, and J.J. Mieyal Glutaredoxin: role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation Antioxid Redox Signal 7 3-4 2005 348 366
162. H. Shen, Z.J. Chen, J.T. Zilfou, E. Hopper, M. Murphy, and K.D. Tew Binding of the aminothiol WR-1065 to transcription factors influences cellular response to anticancer drugs J Pharmacol Exp Ther 297 3 2001 1067 1073
163. S. Short, B.J. Merkel, R. Caffrey, and K.L. McCoy Defective antigen processing correlates with a low level of intracellular glutathione Eur J Immunol 26 12 1996 3015 3020
164. J. Skalska, P.S. Brookes, S.M. Nadtochiy, S.P. Hilchey, C.T. Jordan, and M.L. Guzman Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolide PLoS ONE 4 12 2009 e8115
165. W.C. Su, S.L. Chang, T.Y. Chen, J.S. Chen, and C.J. Tsao Comparison of in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect Jpn J Clin Oncol 30 12 2000 562 567
166. T. Sugiyama, H. Kohara, M. Noda, and T. Nagasawa Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches Immunity 25 6 2006 977 988
167. T.P. Szatrowski, and C.F. Nathan Production of large amounts of hydrogen peroxide by human tumor cells Cancer Res 51 3 1991 794 798
168. M. Tan, S. Li, M. Swaroop, K. Guan, L.W. Oberley, and Y. Sun Transcriptional activation of the human glutathione peroxidase promoter by p53 J Biol Chem 274 17 1999 12061 12066
169. K. Tanaka, J.B. Pracyk, K. Takeda, Z.X. Yu, V.J. Ferrans, and S.S. Deshpande Expression of Id1 results in apoptosis of cardiac myocytes through a redox-dependent mechanism J Biol Chem 273 40 1998 25922 25928
170. K.D. Tew Glutathione-associated enzymes in anticancer drug resistance Cancer Res 54 16 1994 4313 4320
171. K.D. Tew Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation Biochem Pharmacol 73 9 2007 1257 1269
172. Z. Tothova, and D.G. Gilliland FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system Cell Stem Cell 1 2 2007 140 152
173. Z. Tothova, R. Kollipara, B.J. Huntly, B.H. Lee, D.H. Castrillon, and D.E. Cullen FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress Cell 128 2 2007 325 339
174. D.M. Townsend S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response Mol Interv 7 6 2007 313 324
175. D.M. Townsend, M. Deng, L. Zhang, M.G. Lapus, and M.H. Hanigan Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells J Am Soc Nephrol 14 1 2003 1 10
176. D.M. Townsend, L. He, S. Hutchens, T.E. Garrett, C.J. Pazoles, and K.D. Tew NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance Cancer Res 68 8 2008 2870 2877
177. D.M. Townsend, Y. Manevich, L. He, S. Hutchens, C.J. Pazoles, and K.D. Tew Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress J Biol Chem 284 1 2009 436 445
178. D.M. Townsend, C.J. Pazoles, and K.D. Tew NOV-002, a mimetic of glutathione disulfide Expert Opin Investig Drugs 17 7 2008 1075 1083
179. D. Townsend, and K. Tew Cancer drugs, genetic variation and the glutathione-S-transferase gene family Am J Pharmacogenomics 3 3 2003 157 172
180. D.M. Townsend, K.D. Tew, and H. Tapiero The importance of glutathione in human disease Biomed Pharmacother 57 3-4 2003 145 155
181. D. Trachootham, W. Lu, M.A. Ogasawara, R.D. Nilsa, and P. Huang Redox regulation of cell survival Antioxid Redox Signal 10 8 2008 1343 1374
182. M. Utsugi, K. Dobashi, T. Ishizuka, K. Endou, J. Hamuro, and Y. Murata c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production J Immunol 171 2 2003 628 635
183. M. Utsugi, K. Dobashi, Y. Koga, Y. Shimizu, T. Ishizuka, and K. Iizuka Glutathione redox regulates lipopolysaccharide-induced IL-12 production through p38 mitogen-activated protein kinase activation in human monocytes: role of glutathione redox in IFN-gamma priming of IL-12 production J Leukoc Biol 71 2 2002 339 347
184. J.D. Uys, Y. Manevich, L.C. Devane, L. He, T.E. Garret, and C.J. Pazoles Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic Biomed Pharmacother 2010
185. A.J. van der Ven, H.J. Blom, W. Peters, L.E. Jacobs, T.J. Verver, and P.P. Koopmans Glutathione homeostasis is disturbed in CD4-positive lymphocytes of HIV-seropositive individuals Eur J Clin Invest 28 3 1998 187 193
186. M. van Pel, R. van Os, G.A. Velders, H. Hagoort, P.M. Heegaard, and I.J. Lindley Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization Proc Natl Acad Sci USA 103 5 2006 1469 1474
187. C.S. Velu, S.K. Niture, C.E. Doneanu, N. Pattabiraman, and K.S. Srivenugopal Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress Biochemistry 46 26 2007 7765 7780
188. M. Verschraagen, E. Boven, E. Torun, F.H. Hausheer, A. Bast, and W.J. van der Vijgh Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects Biochem Pharmacol 68 3 2004 493 502
189. M. Verschraagen, M.A. Kedde, F.H. Hausheer, and W.J. Van Der Vijgh The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG Cancer Chemother Pharmacol 51 6 2003 499 504
190. M.T. Voso, S. Hohaus, F. Guidi, E. Fabiani, F. D'Alo, and S. Groner Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia Leukemia 22 9 2008 1685 1691
191. Wang, T. T., Zeng, G. C., Li, X. C., & Zeng, H. P. In vitro studies on the antioxidant and protective effect of 2-substituted -8-hydroxyquinoline derivatives against H(2)O(2)-induced oxidative stress in BMSCs. Chem Biol Drug Des 75(2), 214-222.
192. Wilcox, C. S. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther 126(2), 119-145.
193. A. Wilson, E. Laurenti, G. Oser, R.C. van der Wath, W. Blanco-Bose, and M. Jaworski Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair Cell 135 6 2008 1118 1129
194. I.G. Winkler, J. Hendy, P. Coughlin, A. Horvath, and J.P. Levesque Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization J Exp Med 201 7 2005 1077 1088
195. G.T. Wondrak Redox-directed cancer therapeutics: Molecular mechanisms and opportunities Antioxid Redox Signal 11 12 2009 3013 3069
196. S. Yalcin, X. Zhang, J.P. Luciano, S.K. Mungamuri, D. Marinkovic, and C. Vercherat Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells J Biol Chem 283 37 2008 25692 25705
197. 2-induced cell death via coordinated regulation of stress kinases Cancer Res 60 15 2000 4053 4057
198. M. Zafarullah, W.Q. Li, J. Sylvester, and M. Ahmad Molecular mechanisms of N-acetylcysteine actions Cell Mol Life Sci 60 1 2003 6 20
199. H. Zhang, H. Spapen, D.N. Nguyen, P. Rogiers, J. Bakker, and J.L. Vincent Effects of N-acetyl-L-cysteine on regional blood flow during endotoxic shock Eur Surg Res 27 5 1995 292 300
200. H. Zheng, L.M. Weiner, O. Bar-Am, S. Epsztejn, Z.I. Cabantchik, and A. Warshawsky Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases Bioorg Med Chem 13 3 2005 773 783
201. Y. Zhou, E.O. Hileman, W. Plunkett, M.J. Keating, and P. Huang Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents Blood 101 10 2003 4098 4104